Home  >  TopNews
  Amgen announces US FDA approves sNDA to add OS data from phase 3 trial to prescribing information for Kyprolis,   January 19, 2018
  Biohaven to begin clinical development of BHV-5000 to treat Rett syndrome,   January 19, 2018
  Bayer to present new data from Stivarga & Nexavar in advanced liver, colorectal & biliary tract cancers at ASCO GI 2018 cancer symposium,   January 18, 2018
  MyDx to initiate clinical trials on unique MyDx360 pain management formula,   January 18, 2018
  US FDA takes new steps to enhance transparency of trial information to support innovation, scientific inquiry related to new drugs,   January 18, 2018
  Castle Creek Pharma presents phase 2 study results of diacerein 1% ointment to treat EBS at Winter Clinical Dermatology Conference,   January 17, 2018
  Novartis CLARITY study shows Cosentyx more effective than Stelara in delivering clear skin in adults with plaque psoriasis at 12 weeks,   January 17, 2018
  SEMCO aswarded SBIR phase 1 NCI contract to study its lead molecules in preclinical model of triple negative breast cancer,   January 16, 2018
  Dynasil submits Xcede Technologies' application for first-in-human trial,   January 15, 2018
  Glenmark receives DCGI nod to start phase IIb dose range study of GRC 27864 to treat osteoarthritic pain,   January 15, 2018
  MERS antibodies produced in cattle safe, treatment well tolerated in phase 1 trial,   January 15, 2018
  US FDA accepts Resverlogix's phase 3 BETonMACE trial protocol amendments,   January 15, 2018
  Immunovia signs collaboration with Denmark’s Diabetes Center for Strategic Research for pancreas cancer study of new onset diabetics,   January 13, 2018
  Study supports use of short-term HIV treatment interruption in clinical trials,   January 13, 2018
  Syndax Pharma inks clinical collaboration with Genentech to evaluate entinostat in combo with anti-PD-L1 cancer immunotherapy in breast cancer,   January 12, 2018
  RadioMedix, Areva Med begin phase 1 trial of AlphaMedix to treat neuroendocrine tumours,   January 12, 2018
  US FDA accepts InflaRx's IND, company to begin phase IIb trial with IFX-1 in Hidradenitis Suppurativa,   January 11, 2018
  BioProtect begins study of ProSpace biodegradable spacer to protect rectum, lower GI tract during radiation therapy,   January 11, 2018
  Inovio, Parker Institute for Cancer Immunotherapy enter clinical collaboration to evaluate new cancer immunotherapy combinations,   January 11, 2018
  Novartis advances head-to-head superiority trials of Cosentyx versus Humira and proposed biosimilar adalimumab,   January 10, 2018

Copyright © 2016 Saffron Media Pvt. Ltd |